Siderophore-dihydrofolate reductase inhibitor conjugate and application thereof
AssigneeJasan Bio Medicine (Jiaxing) Co., Ltd
InventorsYun He, Yan Guan
Life of this patent
Estimating the term…
Abstract
A conjugate provided. The conjugate is a compound represented by Formula (I), or the conjugate is a stereoisomer, tautomer, homologue, solvate, metabolite, pharmaceutically acceptable salt, or prodrug of the compound represented by Formula (I): where A is a linker, and B is a dihydrofolate reductase inhibitor; R1, R2, R3, R4, and R5 are independently selected from H or C1-6 alkyl; and n1, n2, and n3 are each an integer selected from 0 to 6.
Claims3
A conjugate, being a compound represented by Formula (I), or being a stereoisomer, tautomer, homologue, solvate, or pharmaceutically acceptable salt of the compound represented by Formula (I):
- wherein A is a linker selected from heteroatom-containing alkane, amino acid, or amide, and B is a dihydrofolate reductase inhibitor, the dihydrofolate reductase inhibitor being methotrexate;
- R1, R2, R3, R4, and R5 are independently selected from H or C1-6 alkyl;
- and
- n1, n2, and n3 are each an integer selected from 1 to 3.
Dependencies are inferred from the claim text.